These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 17592683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Review article: the safety profile of tegaserod.
    Schoenfeld P.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():25-30. PubMed ID: 15521852
    [Abstract] [Full Text] [Related]

  • 4. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K, Hazeena K, Thomas V, Kumar S, Jose T, Narayanan P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [Abstract] [Full Text] [Related]

  • 5. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC, Barghout V, McBurney CR, Niecko TE.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):373-80. PubMed ID: 16128674
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tegaserod for the treatment of constipation-predominant irritable bowel syndrome.
    Baker DE.
    Rev Gastroenterol Disord; 2001 Sep 01; 1(4):187-98. PubMed ID: 12120185
    [Abstract] [Full Text] [Related]

  • 11. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Beglinger C.
    Int J Clin Pract; 2002 Sep 01; 56(1):47-51. PubMed ID: 11831835
    [Abstract] [Full Text] [Related]

  • 12. Review article: tegaserod for chronic constipation.
    Johanson JF.
    Aliment Pharmacol Ther; 2004 Nov 01; 20 Suppl 7():20-4. PubMed ID: 15521851
    [Abstract] [Full Text] [Related]

  • 13. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
    Müller-Lissner S, Holtmann G, Rueegg P, Weidinger G, Löffler H.
    Aliment Pharmacol Ther; 2005 Jan 01; 21(1):11-20. PubMed ID: 15644040
    [Abstract] [Full Text] [Related]

  • 14. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B.
    Am J Gastroenterol; 2005 Feb 01; 100(2):362-72. PubMed ID: 15667494
    [Abstract] [Full Text] [Related]

  • 15. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003960. PubMed ID: 17943807
    [Abstract] [Full Text] [Related]

  • 16. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr 17; 18(100):75-9. PubMed ID: 19585728
    [Abstract] [Full Text] [Related]

  • 17. Tegaserod: long-term treatment for irritable bowel syndrome patients with constipation in primary care.
    Layer P, Keller J, Mueller-Lissner S, Rüegg P, Loeffler H.
    Digestion; 2005 Apr 17; 71(4):238-44. PubMed ID: 16024929
    [Abstract] [Full Text] [Related]

  • 18. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
    Khoshoo V, Armstead C, Landry L.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):191-6. PubMed ID: 16393297
    [Abstract] [Full Text] [Related]

  • 19. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA, Barghout V, Kahler KH, Bentkover J, Kurth H, Gralnek IM, Spiegel BM.
    Am J Manag Care; 2005 Apr 01; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [Abstract] [Full Text] [Related]

  • 20. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group.
    Zhonghua Nei Ke Za Zhi; 2003 Feb 01; 42(2):88-90. PubMed ID: 12783702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.